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Arika L. Marchetti 
BUILDING PREDICTION MODELS FOR DEMENTIA 
THE NEED TO ACCOUNT FOR INTERVAL CENSORING AND THE COMPETING 
RISK OF DEATH 
 
Context. Prediction models for dementia are crucial for informing clinical 
decision making in older adults. Previous models have used genotype and age to obtain 
risk scores to determine risk of Alzheimer’s Disease, one of the most common forms of 
dementia (Desikan et al., 2017). However, previous prediction models do not account for 
the fact that the time to dementia onset is unknown, lying between the last negative and 
the first positive dementia diagnosis time (interval censoring). Instead, these models use 
time to diagnosis, which is greater than or equal to the true dementia onset time. 
Furthermore, these models do not account for the competing risk of death which is quite 
frequent among elder adults.  
Objectives. To develop a prediction model for dementia that accounts for interval 
censoring and the competing risk of death. To compare the predictions from this model 
with the predictions from a naïve analysis that ignores interval censoring and the 
competing risk of death. 
Methods. We apply the semiparametric sieve maximum likelihood (SML) 
approach to simultaneously model the cumulative incidence function (CIF) of dementia 
and death while accounting for interval censoring (Bakoyannis, Yu, & Yiannoutsos, 
2017). The SML is implemented using the R package intccr. The CIF curves of dementia 
are compared for the SML and the naïve approach using a dataset from the Indianapolis 
Ibadan Dementia Project.  
v 
Results. The CIF from the SML and the naïve approach illustrated that for 
healthier individuals at baseline, the naïve approach underestimated the incidence of 
dementia compared to the SML, as a result of interval censoring. Individuals with a 
poorer health condition at baseline have a CIF that appears to be overestimated in the 
naïve approach. This is due to older individuals with poor health conditions having an 
elevated risk of death. 
Conclusions. The SML method that accounts for the competing risk of death 
along with interval censoring should be used for fitting prediction/prognostic models of 
dementia to inform clinical decision making in older adults. Without controlling for the 
competing risk of death and interval censoring, the current models can provide invalid 
predictions of the CIF of dementia. 
Giorgos Bakoyannis, PhD, Chair 
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Chapter One Introduction 
 
Dementia 
 
Dementia is the loss of cognitive functioning and behaviors that negatively 
impacts an individual’s daily life (National Institute on Aging, 2017b). The World Health 
Organization (WHO) estimates around 50 million people have some form of dementia 
worldwide (World Health Organization, 2019). There are four major types of dementia, 
and it is common for people to have mixed dementia, which is a combination of two or 
more types of dementia. These types include Lewy Body dementia, frontotemporal 
disorders, vascular dementia, and Alzheimer’s disease (National Institute on Aging, 
2017b). Alzheimer’s disease is characterized by amyloid plaques and neurofibrillary 
tangles in the brain, as well as the loss of connections between neurons. Alzheimer’s 
Disease is the most common form of dementia in older adults, and it affects 
approximately 5.5 million people in the US over the age of 65, and it is the sixth leading 
cause of death in the US (National Institute on Aging, 2017a). 
Risk Factors 
 
Dementia has been found to be associated with non-insulin-dependent diabetes 
mellitus, also known as Type II diabetes (A. Ott et al., 1996). In addition to diabetes as a 
potential risk factor for Alzheimer’s disease, there are multiple other risk factors that 
could be included that are associated with diabetes. Excess body fat has been shown to be 
associated with increased risk of Type-2 diabetes in women (Hu et al., 2001). One study 
used a GSMR method that performed a randomization analysis to test for associations 
between common health risk factors. This study found that LDL-cholesterol has a 
protective effect against type-2 diabetes, the number of years of education has a 
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protective effect against Alzheimer’s disease, and an increase in BMI increases the risk of 
type 2 diabetes, but Type-2 diabetes reduces the risk of high BMI (Zhu et al., 2018). 
While diabetes has been found to be associated with a cognitive decline, interventions 
before the age of 60 have been found to lessen this cognitive decline. This was assessed 
using multivariate analysis while controlling for demographics to compare scores on the 
cognitive tests. The change scores were controlled for risk factors such as age, gender, 
center, educational level, site, and CNS-relevant medications using linear regression 
(Knopman et al., 2001).  
Not only has diabetes been associated with Alzheimer’s disease and related 
syndromes, or ADRS, but Alzheimer’s can also influence diabetes as well. ADRS was 
found to be associated with a decrease in monitoring of diabetes and therefore an increase 
in complications due to diabetes. The study compared groups with and without ADRS 
using standardized incidence ratios. Data of censored records was used up until the time 
of censoring (Wargny et al., 2018). This study suggests that Alzheimer’s disease can have 
other impacts on the health of individuals, possibly creating a cycle of health problems.  
Age has an effect on dementia as well. Older ages have been associated with higher 
risk. Gender also has an effect on dementia; similar incidence rates of dementia were 
found in men and women up to age 85, but the lifetime risk of dementia was found to be 
higher in women than in men. This also reflects the fact that women have a higher life 
expectancy than men (Alewijn Ott, Breteler, Harskamp, Stijnen, & Hofman, 1998). Low 
level of education was also found to be significantly associated with dementia (Zhang et 
al., 1990). 
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Prediction/Prognostic Models 
Prognostic models can be used to predict the risk of an event occurring in the 
future, such as developing a disease (Cook, 2008). Prognostic models is a term used to 
describe clinical prediction models. Prediction models of a certain prognosis are useful 
for physicians to make decisions about screening and treatment or therapy for individuals 
that are at a high risk of developing the disease. Clinical prediction models can provide 
evidence of risks in order for the physician and individual to work together for decision 
making as well (Steyerberg, 2008). To be useful in a clinical setting, these models need to 
be valid methodologically (Perel, Edwards, Wentz, & Roberts, 2006). Predictive 
modeling performs a risk assessment to identify individuals that are at risk for a specific 
disease, which allows time for action. They can be used to determine the best clinical 
choices for the patient in a specific situation, as well as used in decisions about the 
overall healthcare system (Vogenberg, 2009).  
Decline in cognitive functions has been found to occur years before dementia can 
be clinically diagnosed (Amieva et al., 2005). The importance of studying preventive 
treatments administered before the onset of Alzheimer’s symptoms for individuals at high 
risk of developing Alzheimer’s is of scientific interest as well (Aisen et al., 2011). 
Epidemiological studies are being used to determine which risk factors have effects on 
the outcome of dementia, and the risks and benefits of various prevention strategies. This 
information can then be relayed to physicians (Patterson et al., 2008). Potential treatment 
options include behavioral modifications and both non-pharmacological and 
pharmacological interventions to manage symptoms (Mayo Clinic, 2019). However, a 
review of some pharmacological therapies has suggested they may not be as effective in 
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managing symptoms of dementia (Sink, Holden, & Yaffe, 2005). Further research is 
needed to determine associations between risk factors and dementia in order to 
individualize treatment based on known present risk factors, and prognostic models may 
be useful in this aspect. 
Previous prediction models for Alzheimer’s Disease do not account for the fact that 
the time to dementia onset is unknown, resulting in interval censoring. Instead, these 
models use time to diagnosis, which is greater than or equal to the true dementia onset 
time. Furthermore, these models do not account for the competing risk of death which is 
quite frequent among elder adults. Previous models have used genotype and age to obtain 
risk scores to determine risk of Alzheimer’s Disease, one of the most common forms of 
dementia. The age of Alzheimer’s onset was taken at the time when symptoms began. 
(Desikan et al., 2017). The landmark Rotterdam Study used the midpoint between 
baseline age and age at diagnosis (Alewijn Ott et al., 1998). Accuracy of predictive tools 
have been assessed using area under the Receiver Operating Characteristic (AUC) and 
Brier Scores (BS) for data with competing risks. However, this study also used the mid-
point between diagnosis and the time of last visit without dementia (Blanche et al., 2015).  
Previous models have accounted for competing risks in various ways, but few studies 
have looked at interval censoring and the competing risk of death in dementia prognostic 
models. Competing risks have been found to be critical in assessing the risk of disease for 
older individuals. Standard univariate survival analysis without competing risks was 
found to overestimate risk of hip fracture when compared to estimates accounting for 
competing risks (Berry, Ngo, Samelson, & Kiel, 2010). Smoking, death, and Alzheimer’s 
Disease were assessed with competing risk of death due to the association between 
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smoking and death. Failure to account for this competing risk of death resulted in biased 
results (Chang, Zhao, Lee, & Ganguli, 2012).  
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Chapter Two Methodology  
Survival Analysis 
 Survival analysis is a method of analyzing data to assess the time to an event of 
interest. In the health-related field, this event is commonly diagnosis of a disease or 
death. The survival probability is the probability that an individual survives from the start 
of the study or event to a specific time. Common approaches to survival analysis include 
the nonparametric Kaplan-Meier estimator and the semiparametric Cox proportional 
hazards model. Data in survival analysis may be censored in different ways. Examples of 
censoring include the fact that not all individuals will have experienced the event during 
the study time, patients may be lost to follow-up for part of the study or the rest of the 
study, or a competing event may occur (Clark, Bradburn, Love, & Altman, 2003). 
Competing Risks and Interval Censoring 
Competing risks are alternative events that could occur which would prevent the 
observation of the event of interest. One of the major types of competing risks is death. If 
death should occur, it is unknown whether that individual would continue to live to the 
end of the study without experiencing the event of interest, or if the individual would 
develop the event of interest. Should these competing events be considered censored data, 
this may create bias in certain estimates, such as the Kaplan-Meier estimator (Putter, 
Fiocco, & Geskus, 2007). Even when the Kaplan Meier accounts for competing risk, the 
results are biased by tending to overestimate event rates, and the “cumulative incidence 
competing risks” method should be used instead. Kaplan-Meier approaches to competing 
risk data include the Kaplan-Meier censor all method, in which individuals are 
considered censored if a competing risk event occurs, the Kaplan-Meier censor death 
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only method, in which individuals are only censored if they experience death before the 
event of interest or are lost to follow-up while other competing risks are ignored, and the 
Kaplan-Meier ignore all method, which ignores all competing risks and only individuals 
lost to follow-up are censored. The Kaplan-Meier methods rely on the assumption that 
the censoring and the event of interest are independent, whereas the cumulative incidence 
competing risks method does not (Southern et al., 2006; Tai, Machin, White, & Gebski, 
2001). 
When addressing data with competing risks, there are two quantities of interest. The 
Cause-Specific Hazard reflects the instantaneous failure rate from a specific event in the 
presence of all other events. The Fine-Gray model, a more simple and straightforward 
approach than the Cumulative Specific Proportional Hazards model, creates a survival 
model based on the cumulative incidence function (Fine & Gray, 1999). The Cumulative 
Incidence Function (CIF), which is the cumulative probability of an event in the presence 
of all other events, is commonly used in prediction and prognosis models as it quantifies 
the absolute risk of an over time (Bakoyannis et al., 2017). More precisely, the CIF is 
defined as: 
 
 
 
Interval censoring occurs when the event of interest occurs between two observation 
times, such as two clinical visits (Putter et al., 2007). The standard Cox model does not 
account for interval censoring (Leffondré, Touraine, Helmer, & Joly, 2013). Previous 
“illness-death" models used a semi-parametric approach to model interval-censored data 
𝐹𝑗  𝑡 = Pr 𝑇 ≤ 𝑡,𝐶 = 𝑗 =  𝜆𝑗  𝑢 𝑒𝑥𝑝  −  𝜆𝑗
𝑘
𝑐=1
 𝑤 𝑑𝑤
𝑢
0
 𝑑𝑢
𝑡
0
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and the estimates were found to be better than those of a more naïve survival model, 
especially when there were high mortality rates present that tended to increase the 
relative bias in other models. However, the interval censoring in this study differed in the 
interval that was observed. This study looked at the probability that an individual 
developed the disease between the last visit time and the time of death (Leffondré et al., 
2013).  
Estimation Methodology 
 
A method to analyze interval-censored competing risks data was proposed by 
Bakoyannis, Yu, and Yiannoutsos (Bakoyannis et al., 2017). This method is based on a 
B-spline sieve maximum likelihood (SML) and estimates a class of semiparametric 
generalized odds rate transformation models for the cause-specific CIF. 
The likelihood function accounts for interval censoring by including the interval 
in the equation, using the last observation time prior to the event (V) and the first 
observation time after the event (U) as well as unique indicator functions for the interval 
censoring and left censoring. The unknown parameters to be estimated are θ= (θ’1, θ’2), 
and the vector of the covariates of interest is Z. The indicator function δij is used to 
express which individual (i) experienced which event (j) when the event time is interval-
censored, while the indicator function 𝛿𝑖𝑗
1  indicates when the time is left-censored (Park, 
Bakoyannis, & Yiannoutsos, 2019).  
 
 
 
 
 9 
The likelihood function for interval-censored data is therefore 
  
 
 
 
Semiparametric models for the CIFs are considered in the aforementioned methodology. 
These models contain both non-parametric and parametric parts. The nonparametric part 
is approximation using B-splines. A general class of semiparametric models for the CIF 
is the class of semiparametric transformation models which has the form 
 
 
The method by Bakoyannis et al. estimates a special subset of the class of semiparametric 
transformation models, known as the Generalized Odds-Rate Transformation models 
(Bakoyannis et al., 2017). 
 
 
 
The Fine-Gray model is a specific member of the class of Generalized Odds-Rate 
Transformation models in which the alpha value equals zero, while the proportional odds 
model has an alpha value equal to one (Jeong & Fine, 2006; Park et al., 2019). 
The semiparametric SML approach is used to estimate the parameters of these 
models under the likelihood defined above. This method produces regression coefficient 
estimates that are consistent, asymptotically normal, and semi-parametrically efficient 
𝐿 θ;𝐷  ∝      [
𝑘
𝑗=1
𝐹𝑗  𝑈𝑖 ;𝒁𝑖 ,𝜽𝑗  −  𝐹𝑗  𝑉𝑖 ;𝒁𝑖 ,𝜽𝑗 )]
𝛿𝑖𝑗   
𝑛
𝑖=1
×   [𝐹𝑗  𝑈𝑖 ;𝒁𝑖 ,𝜽𝑗  ]
𝛿𝑖𝑗
1
𝑘
𝑗=1
   1 − 𝐹𝑗 (𝑉𝑖;𝒁𝑖 ,𝜽𝑗 )
𝑘
𝑗=1
 
1−𝛿𝑖
  
𝑔𝒋 𝐹𝒋 𝑡; 𝒛  = 𝜑𝑗  𝑡 + 𝛽𝑗
𝑇𝒛 
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(Bakoyannis et al., 2017). In this work we use the above estimation methodology to 
develop a prediction model for dementia that accounts for interval censoring and the 
competing risk of death. Then, predictions from this model are compared to naïve 
predictions that ignore interval censoring and the competing risk of death by using a Cox 
hazards model. 
Intccr R Package 
 
The intccr package uses the function ciregic to fit the semiparametric regression 
model for the CIF that is in the class of generalized odds rate transformation models for 
this type of dataset that contains interval censoring and competing risk of death. It does 
this by assigning values to the competing event types (death or dementia) and identifying 
the right censored observations. The package utilizes parallel computing for a more 
efficient bootstrap variance-covariance matrix (Park et al., 2019). 
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Chapter Three Results 
 
Participant Sample 
 
The data used in the analysis came from a longitudinal study called the Indianapolis-
Ibadan Dementia Project. The project contained data on two different populations, elderly 
African Americans from Indianapolis and elderly Yoruba from Ibadan, Nigeria. Our 
subset of data was from the Indianapolis cohort, and contained information on various 
potential risk factors for dementia. Participants were also classified as being in the new or 
old cohort depending on when they were enrolled in the study. Cohorts were enrolled in 
1992 and in 2001 (Murray et al., 2018). 
Statistical Analysis 
 
First, we created a baseline dataset to identify status of each risk factor at baseline 
as well as the right censoring events to identify if the individual survived without 
dementia, developed dementia, or died as well as the interval in which the event occurred 
in terms of their age. Individuals that died before the age of 65 were removed as we 
wanted to only look at individuals surviving to the age of 65 which were dementia-free at 
that age. The intccr R package function ciregic (Park et al., 2019) was then applied to fit 
semiparametric models for the CIF using the B-spline SML approach by Bakoyannis et 
al. (2017).  
We performed a model selection and selected the Fine-Gray model for dementia 
and the proportional odds model for death because they produced the greatest log-
likelihood. A backwards selection of variables was performed to determine the variables 
that should be included in the Fine-Gray model based on a p-value cutoff of 0.05. The 
variables selected in backwards selection for dementia were baseline depression, baseline 
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heart attack status, and baseline stroke, while the variables selected for death were sex, 
baseline diabetes, baseline alcoholism, baseline depression, baseline heart attack status, 
baseline stroke status, and baseline smoking status.  
The Fine-Gray model of the CIF was performed for dementia and death 
individually, and the estimates can be found in Table 1. 
Table 1. Fine-Gray Model of Dementia Results 
 
Parameter Estimate Standard Error P value Hazard Ratio 
Sex (F) -0.00705  0.10852 0.9482 0.993 
Baseline Diabetes -0.30712 0.11476 0.0074 0.736 
Baseline Alcohol -0.12256 0.11001 0.2652 0.885 
Baseline 
Depressed 
0.29304 0.15396 0.0570 1.341 
Baseline Stroke 0.22833 0.13067 0.0806 1.257 
Baseline Smoking -0.39396 0.10253 0.0001 0.674 
 
Statistical Analysis Results 
The total number of individuals in the dataset was 4,095. 34.55% of the 
individuals did not develop dementia, 11.01% developed dementia, and 54.43% died 
before the end of the study (Table 2). 
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Table 2. Baseline Descriptive Statistics of Selected Variables for Participants without 
Dementia, with Dementia, and Participants that Died. 
 
  
Final Dementia status 
 
Total Individuals 
  
No Dementia Dementia Died 
 
  N (%) N(%) N(%) N(%) 
Total Individuals 1415 (34.55) 451 (11.01) 2229 (54.43) 4095 (100) 
Baseline 
Diabetes status 
No 
Diabetes 1097 (77.53) 345 (76.50) 1524 (68.37) 2966 (72.43) 
 
Diabetes 318 (22.47) 106 (23.50) 705 (31.63) 1129 (27.57) 
Gender Female 1022 (72.23) 305 (67.63) 1333 (59.80) 2660 (64.96) 
 
Male 393 (27.77) 146 (32.37) 896 (40.20) 1435 (35.04) 
Cohort New 966 (68.27) 151 (33.48) 767 (34.41) 1884 (46.01) 
 
Old 449 (31.73) 300 (66.52) 1462 (65.59) 2211 (53.99) 
 
Final Dementia status 
 
Total Individuals 
 
No Dementia Dementia Died 
 
 Median [IQR] Median [IQR] Median [IQR] Median [IQR] 
Years of education 12.00 [10.00,13.00] 9.00 [8.00, 12.00] 11.00 [8.00, 12.00] 11.00 [8.00, 12.00] 
Baseline Age 73.58 [70.87, 77.81] 78.08 [72.93, 83.06] 75.21 [70.82, 80.49] 74.92 [70.99, 79.96] 
 
 
For the purpose of the plots of the CIF for both the naïve Cox Proportional Hazards 
models and the SML models, covariate patterns known to be associated with dementia 
were used to observe the changes in the curves. The CIFs of dementia were plotted 
against age for males and females for the SML model and the naïve analysis. 
The CIF from the SML and the naïve approach illustrated that for healthier 
individuals at baseline, the naïve approach underestimated the incidence of dementia 
compared to the SML, as a result of interval censoring (Fig 1). Individuals with a poorer 
health condition at baseline have a CIF that appears to be overestimated in the naïve 
approach (Fig 2). This is due to the fact that older individuals with a poor health 
condition have an elevated risk of the competing risk of death. Looking at one baseline 
risk factor at a time, for example, diabetes, shows us that the naïve approach 
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underestimates the CIF until approximately age 80, after which it begins to overestimate 
the CIF compared to the SML approach (Fig 3). The initial underestimation is a result of 
interval censoring, whereas the final overestimation is result of the competing risk of 
death at older ages.
 
Figure 1. Cumulative Incidence Function of Dementia for Naïve Model and the Sieve 
Maximum Likelihood (SML) Model over Time Stratified by Gender for Individuals 
without Any Selected Risk Factors Present at Baseline.  
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Figure 2. Cumulative Incidence Function of Dementia for Naïve Model and SML Model 
over Time Stratified by Gender for Individuals with All Selected Risk Factors Present at 
Baseline. 
 
Figure 3. Cumulative Incidence Function of Dementia for Naïve Model and SML Model 
over Time Stratified by Gender for Individuals with Diabetes Present at Baseline. 
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Chapter Four Conclusions 
 
While naïve approaches may be finding important and novel knowledge of 
associations between risk factors and diseases, they also yield biased results due to many 
prognostic models for dementia not accounting for interval censoring or competing risk 
of death. Interval censoring either puts the time of dementia onset at the midpoint 
between the last clinical visit or observed timepoint without diagnosis and the clinical 
visit or observed timepoint with diagnosis, or at the clinical visit or observed timepoint of 
diagnosis. The significant competing risk of death arises from the fact that dementia 
studies involve older adults with a higher mortality rate. This needs to be accounted for 
when building prediction models for dementia. 
The intccr R package and ciregic function allow both interval censoring and 
competing risk to be controlled for by fitting a semiparametric SML approach to model 
the CIF of dementia while accounting for interval censoring. When applying this to 
prognostic factors in the Indianapolis Ibadan Dementia Project dataset, the CIF curves for 
the naïve analysis differ from our analysis depending on the age and the risk factors 
present. 
In conclusion, the SML method that accounts for the competing risk of death along 
with interval censoring should be used for fitting prediction or prognostic models of 
dementia to inform clinical decision making in older adults. Without controlling for the 
competing risk of death and interval censoring, the current models can provide invalid 
predictions of the CIF of dementia. This indicates that accounting for interval censoring 
and the competing risk of death is necessary for dementia predictive modeling. While this 
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study does not consider time dependent covariates, future studies could address this as 
well. 
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